Browsing by Subject "530/350"
Now showing items 21-32 of 32
-
(United States. Patent and Trademark Office; Texas A&M University. Libraries, 2010-05-04)Methods for treating or preventing infections from coagulase-negative staphylococci using proteins and polypeptides from coagulase-negative staphylococcal bacteria such as S. epidermidis, including proteins designated SdrF, ...
-
(United States. Patent and Trademark Office; Texas A&M University. Libraries, 2009-06-09)The present invention provides recombinant triple helical proteins or collagen-like proteins comprising a prokaryotic protein or one or more domains of a prokaryotic protein comprising a collagen-like peptide sequence of ...
-
(United States. Patent and Trademark Office; Texas A&M University. Libraries, 2005-10-11)The present invention provides recombinant triple helical proteins or collagen-like proteins comprising a prokaryotic protein or one or more domains of a prokaryotic protein comprising a collagen-like peptide sequence of ...
-
(United States. Patent and Trademark Office; Texas A&M University. Libraries, 2007-07-03)The present invention provides recombinant triple helical proteins or collagen-like proteins comprising a prokaryotic protein or one or more domains of a prokaryotic protein comprising a collagen-like peptide sequence of ...
-
(United States. Patent and Trademark Office; Texas A&M University. Libraries, 2010-04-20)The present invention provides recombinant triple helical proteins or collagen-like proteins comprising a prokaryotic protein or one or more domains of a prokaryotic protein comprising a collagen-like peptide sequence of ...
-
(United States. Patent and Trademark Office; Texas A&M University. Libraries, 2009-01-06)Proteins and polypeptides from coagulase-negative staphylococcal bacteria such as S. epidermidis, including proteins designated SdrF, SdrG and SdrH, and their effective fragments such as their respective A domains, are ...
-
(United States. Patent and Trademark Office; Texas A&M University. Libraries, 1998-09-08)This invention discloses the DNA sequences coding for the Actinobacillus pleuropneumonia hemolysin(s). It further discloses a method of producing the A. pleuropneumoniae hemolysin(s) from recombinant cells. It also provides ...
-
(United States. Patent and Trademark Office; Texas A&M University. Libraries, 2010-10-19)An isolated extracellular matrix-binding protein, designated as SdrC and its corresponding amino acid and nucleic acid sequences and motifs are described. The proteins, peptides, fragments thereof or antigenic portions ...
-
(United States. Patent and Trademark Office; Texas A&M University. Libraries, 2010-11-16)An isolated extracellular matrix-binding protein, designated as SdrD and its corresponding amino acid and nucleic acid sequences and motifs are described. The proteins, peptides, fragments thereof or antigenic portions ...
-
(United States. Patent and Trademark Office; Texas A&M University. Libraries, 2010-12-21)An isolated extracellular matrix-binding protein, designated as SdrE and its corresponding amino acid and nucleic acid sequences and motifs are described. The proteins, peptides, fragments thereof or antigenic portions ...
-
(United States. Patent and Trademark Office; Texas A&M University. Libraries, 2013-06-18)The present invention is drawn to methods of stimulating or enhancing angiogenesis in a patient comprising, administering to said patient a therapeutically effective amount of an endorepellin protein, wherein said endorepellin ...
-
(United States. Patent and Trademark Office; Texas A&M University. Libraries, 1998-02-17)The present invention is an improved vaccine against Brucella abortus which permits differentiation between vaccinated and field strain infected cattle. The vaccine can be administered in two different forms: (1) cell ...